Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Express Scripts Holding Co. (ESRX) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Express Scripts Holding Co.. Table 2 shows the detailed insider transactions. This company's CIK number is 1532063.
Total stock buying since 2014: $489,000.
Total stock sales since 2014: $90,274,449.
Total stock option exercises since 2014: $65,214,101.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 0 | $0 | 59,813 | $4,875,044 | 284,281 | $15,704,685 |
| 2017 | 8,000 | $489,000 | 20,963 | $1,414,535 | 291,887 | $11,107,561 |
| 2016 | 0 | $0 | 60,857 | $4,429,292 | 77,666 | $2,912,476 |
| 2015 | 0 | $0 | 133,231 | $11,548,958 | 109,148 | $5,672,512 |
| 2014 | 0 | $0 | 944,329 | $68,006,620 | 929,783 | $29,816,867 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-11 | 0 | $0 | 5,234 | $520,793 | 0 | $0 |
| 2018-10 | 0 | $0 | 0 | $0 | 5,464 | $255,168 |
| 2018-08 | 0 | $0 | 12,898 | $1,096,330 | 12,898 | $684,238 |
| 2018-06 | 0 | $0 | 10,000 | $822,800 | 10,000 | $530,500 |
| 2018-04 | 0 | $0 | 0 | $0 | 29,864 | $1,719,864 |
| 2018-03 | 0 | $0 | 24,784 | $1,893,704 | 222,251 | $12,303,994 |
| 2018-02 | 0 | $0 | 0 | $0 | 3,646 | $199,035 |
| 2018-01 | 0 | $0 | 6,897 | $541,417 | 158 | $11,886 |
| 2017-12 | 0 | $0 | 10,104 | $708,047 | 10,104 | $570,876 |
| 2017-11 | 0 | $0 | 643 | $40,104 | 0 | $0 |
| 2017-10 | 8,000 | $489,000 | 0 | $0 | 0 | $0 |
| 2017-09 | 0 | $0 | 4,478 | $285,832 | 0 | $0 |
| 2017-08 | 0 | $0 | 1,163 | $71,501 | 0 | $0 |
| 2017-06 | 0 | $0 | 0 | $0 | 69,847 | $0 |
| 2017-05 | 0 | $0 | 1,100 | $66,088 | 24,126 | $1,236,336 |
| 2017-04 | 0 | $0 | 0 | $0 | 2,682 | $137,439 |
| 2017-03 | 0 | $0 | 2,352 | $165,016 | 185,128 | $9,162,910 |
| 2017-01 | 0 | $0 | 1,123 | $77,947 | 0 | $0 |
| 2016-11 | 0 | $0 | 22,440 | $1,683,334 | 21,798 | $1,078,892 |
| 2016-09 | 0 | $0 | 13,821 | $973,706 | 12,036 | $688,856 |
| 2016-05 | 0 | $0 | 800 | $59,288 | 4,748 | $146,380 |
| 2016-04 | 0 | $0 | 5,482 | $405,300 | 13,128 | $404,736 |
| 2016-03 | 0 | $0 | 18,314 | $1,307,664 | 25,956 | $593,612 |
| 2015-06 | 0 | $0 | 47,713 | $4,112,103 | 46,069 | $2,744,975 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-11-07 | Mac Mahon Thomas P (Director) | Sale | 5,234 | 99.50 | 520,793 |
| 2018-10-26 | Delaney William J Iii (Director) | Option Ex | 5,464 | 46.70 | 255,168 |
| 2018-08-10 | Houston Christine (Executive Vice President) | Sale | 12,898 | 85.00 | 1,096,330 |
| 2018-08-10 | Houston Christine (Executive Vice President) | Option Ex | 12,898 | 53.05 | 684,238 |
| 2018-06-13 | Houston Christine (Executive Vice President) | Sale | 10,000 | 82.28 | 822,800 |
| 2018-06-13 | Houston Christine (Executive Vice President) | Option Ex | 10,000 | 53.05 | 530,500 |
| 2018-04-27 | Breen Maura C (Director) | Option Ex | 7,466 | 57.59 | 429,966 |
| 2018-04-26 | Mergenthaler Frank (Director) | Option Ex | 7,466 | 57.59 | 429,966 |
| 2018-04-26 | Lahowchic Nicholas (Director) | Option Ex | 7,466 | 57.59 | 429,966 |
| 2018-04-26 | Mac Mahon Thomas P (Director) | Option Ex | 7,466 | 57.59 | 429,966 |
| 2018-03-15 | Houston Christine (Executive Vice President) | Sale | 19,889 | 76.69 | 1,525,307 |
| 2018-03-15 | Houston Christine (Executive Vice President) | Option Ex | 19,889 | 43.77 | 870,541 |
| 2018-03-02 | Miller Steven B (Sr. VP & Chief Med. Officer) | Option Ex | 20,348 | 56.50 | 1,149,662 |
| 2018-03-02 | Wade Sara E (Sr. VP and Ch. Human Res. Off.) | Option Ex | 20,348 | 56.50 | 1,149,662 |
| 2018-03-02 | Paz George (Director) | Option Ex | 161,666 | 56.50 | 9,134,129 |
| 2018-03-01 | Neville Everett (Exe VP, Strat, Sup Chn & Spclt) | Sale | 4,895 | 75.26 | 368,397 |
| 2018-02-22 | Wade Sara E (Sr. VP and Ch. Human Res. Off.) | Option Ex | 3,646 | 54.59 | 199,035 |
| 2018-01-11 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Sale | 3,449 | 81.00 | 279,369 |
| 2018-01-02 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Sale | 3,448 | 76.00 | 262,048 |
| 2018-01-02 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Option Ex | 158 | 75.23 | 11,886 |
| 2017-12-15 | Houston Christine (Executive VP & COO) | Sale | 10,104 | 70.08 | 708,047 |
| 2017-12-15 | Houston Christine (Executive VP & COO) | Option Ex | 10,104 | 56.50 | 570,876 |
| 2017-11-01 | Anderson Phyllis S. (Sr. VP & Ch. Marketing Officer) | Sale | 643 | 62.37 | 40,104 |
| 2017-10-31 | Wentworth Timothy C (President & CEO) | Buy | 8,000 | 61.12 | 489,000 |
| 2017-09-11 | Myers Woodrow A Jr (Director) | Sale | 3,900 | 63.93 | 249,342 |
| 2017-09-08 | Anderson Phyllis S. (Sr. VP & Ch. Marketing Officer) | Sale | 578 | 63.13 | 36,490 |
| 2017-08-23 | Neville Everett (Sr. VP, Sup. Chain & Specialty) | Sale | 1,163 | 61.48 | 71,501 |
| 2017-06-01 | Paz George (Director) | Option Ex | 69,847 | .00 | 0 |
| 2017-05-19 | Anderson Phyllis S. (Sr. VP & Ch. Marketing Officer) | Sale | 1,100 | 60.08 | 66,088 |
| 2017-05-05 | Mergenthaler Frank (Director) | Option Ex | 8,042 | 51.24 | 412,112 |
| 2017-05-05 | Breen Maura C (Director) | Option Ex | 8,042 | 51.24 | 412,112 |
| 2017-05-05 | Mac Mahon Thomas P (Director) | Option Ex | 8,042 | 51.24 | 412,112 |
| 2017-04-28 | Lahowchic Nicholas (Director) | Option Ex | 2,682 | 51.24 | 137,439 |
| 2017-03-03 | Houston Christine (Executive VP & COO) | Option Ex | 10,742 | 49.49 | 531,675 |
| 2017-03-03 | Paz George (Director) | Option Ex | 174,386 | 49.49 | 8,631,235 |
| 2017-03-01 | Neville Everett (Sr VP-Supply Chain & Specialty) | Sale | 2,352 | 70.16 | 165,016 |
| 2017-01-03 | Neville Everett (Sr. VP, Sup. Chain & Specialty) | Sale | 1,123 | 69.41 | 77,947 |
| 2016-11-09 | Anderson Phyllis S. (Sr. VP & Ch. Marketing Officer) | Sale | 642 | 74.74 | 47,983 |
| 2016-11-09 | Miller Steven B (Sr. VP & Chief Med. Officer) | Sale | 21,798 | 75.02 | 1,635,351 |
| 2016-11-09 | Miller Steven B (Sr. VP & Chief Med. Officer) | Option Ex | 21,798 | 49.49 | 1,078,892 |
| 2016-09-14 | Myers Woodrow A Jr (Director) | Sale | 12,036 | 70.40 | 847,382 |
| 2016-09-14 | Myers Woodrow A Jr (Director) | Option Ex | 12,036 | 57.23 | 688,856 |
| 2016-09-12 | Mcginnis Christopher A (VP, Controller & Ch. Acct. Officer) | Sale | 1,785 | 70.77 | 126,324 |
| 2016-05-27 | Mergenthaler Frank (Director) | Option Ex | 4,748 | 30.83 | 146,380 |
| 2016-05-10 | Neville Everett (Senior VP, Supply Chain) | Sale | 800 | 74.11 | 59,288 |
| 2016-04-29 | Mac Mahon Thomas P (Director) | Sale | 5,482 | 73.93 | 405,300 |
| 2016-04-29 | Mac Mahon Thomas P (Director) | Option Ex | 13,128 | 30.83 | 404,736 |
| 2016-03-10 | Mcginnis Christopher A (VP, Controller & Ch. Acct. Officer) | Sale | 579 | 68.56 | 39,693 |
| 2016-03-07 | Anderson Phyllis S. (Sr. VP & Ch. Marketing Officer) | Sale | 614 | 71.14 | 43,680 |
| 2016-03-02 | Mergenthaler Frank (Director) | Option Ex | 10,954 | 22.87 | 250,517 |
| 2016-03-02 | Sternberg Seymour (Director) | Sale | 8,400 | 71.47 | 600,348 |
| 2016-03-01 | Houston Christine (Senior VP, Operations) | Sale | 8,721 | 71.55 | 623,943 |
| 2016-03-01 | Houston Christine (Senior VP, Operations) | Option Ex | 15,002 | 22.87 | 343,095 |
| 2015-06-09 | Wimberly Gary (Sr. VP & Ch. Information Off.) | Sale | 1,644 | 87.14 | 143,259 |
| 2015-06-01 | Wimberly Gary (Sr. VP & Ch. Information Off.) | Sale | 46,069 | 86.15 | 3,968,844 |
| 2015-06-01 | Wimberly Gary (Sr. VP & Ch. Information Off.) | Option Ex | 46,069 | 59.58 | 2,744,975 |
| 2015-05-27 | Sternberg Seymour (Director) | Sale | 6,870 | 90.23 | 619,859 |
| 2015-05-27 | Sternberg Seymour (Director) | Option Ex | 6,870 | 52.53 | 360,881 |
| 2015-05-08 | Myers Woodrow A Jr (Director) | Sale | 14,342 | 85.32 | 1,223,645 |
| 2015-05-08 | Myers Woodrow A Jr (Director) | Option Ex | 14,342 | 54.42 | 780,462 |
| 2015-05-04 | Benanav Gary G (Director) | Sale | 10,000 | 87.39 | 873,850 |
| 2015-05-04 | Benanav Gary G (Director) | Option Ex | 13,128 | 30.83 | 404,736 |
| 2015-05-01 | Norton David A (SVP, Specialty & Supply Chain) | Sale | 12,029 | 86.53 | 1,040,809 |
| 2015-05-01 | Norton David A (SVP, Specialty & Supply Chain) | Option Ex | 7,000 | 49.49 | 346,465 |
| 2015-05-01 | Wade Sara E (Sr. VP, Ch. Human Res. Off.) | Sale | 12,000 | 86.53 | 1,038,300 |
| 2015-03-02 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Sale | 2,674 | 84.39 | 225,658 |
| 2015-02-25 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Sale | 5,864 | 87.31 | 511,985 |
| 2015-02-24 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Sale | 21,739 | 87.53 | 1,902,749 |
| 2015-02-24 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Option Ex | 21,739 | 47.61 | 1,034,993 |
| 2014-12-02 | Ebling Keith J. (Exec. VP and General Counsel) | Sale | 10,000 | 84.25 | 842,500 |
| 2014-12-01 | Miller Steven B (Sr. VP & Chief Med. Officer) | Sale | 4,896 | 83.57 | 409,144 |
| 2014-11-28 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Sale | 10,800 | 82.96 | 895,946 |
| 2014-11-28 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Option Ex | 10,800 | 47.61 | 514,188 |
| 2014-11-21 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Sale | 10,874 | 81.50 | 886,231 |
| 2014-11-21 | Stettin Glen D. (Sr. VP, Clin. Res. & New Sol.) | Option Ex | 10,874 | 47.61 | 517,711 |
| 2014-11-21 | Mac Mahon Thomas P (Director) | Sale | 12,694 | 80.93 | 1,027,350 |
| 2014-11-21 | Mac Mahon Thomas P (Director) | Option Ex | 12,694 | 35.84 | 455,016 |
| 2014-11-17 | Parker John O (Director) | Sale | 25,822 | 78.75 | 2,033,430 |
| 2014-11-17 | Parker John O (Director) | Option Ex | 25,822 | 33.34 | 860,853 |
| 2014-09-05 | Ignaczak Edward B (EVP) | Sale | 9,886 | 75.28 | 744,218 |
| 2014-08-28 | Sternberg Seymour (Director) | Sale | 15,508 | 74.12 | 1,149,390 |
| 2014-08-28 | Sternberg Seymour (Director) | Option Ex | 15,508 | 54.42 | 843,914 |
| 2014-08-25 | Ebling Keith J. (Exec. VP and General Counsel) | Sale | 10,000 | 75.50 | 755,000 |
| 2014-08-05 | Wade Sara E (Sr. VP, Ch. Human Res. Off.) | Sale | 20,000 | 70.44 | 1,408,800 |
| 2014-08-05 | Wade Sara E (Sr. VP, Ch. Human Res. Off.) | Option Ex | 20,000 | 53.05 | 1,061,000 |
| 2014-08-05 | Benanav Gary G (Director) | Sale | 12,694 | 70.82 | 898,989 |
| 2014-08-05 | Benanav Gary G (Director) | Option Ex | 12,694 | 35.84 | 455,016 |
| 2014-08-04 | Norton David A (Senior VP, Supply Chain) | Sale | 1,276 | 71.02 | 90,626 |
| 2014-08-01 | Breen Maura C (Director) | Sale | 12,694 | 69.94 | 887,754 |
| 2014-08-01 | Breen Maura C (Director) | Option Ex | 12,694 | 35.84 | 455,016 |
| 2014-06-13 | Paz George (Chairman & CEO) | Sale | 681,508 | 71.21 | 48,530,184 |
| 2014-06-13 | Paz George (Chairman & CEO) | Option Ex | 681,508 | 27.39 | 18,669,911 |
| 2014-05-27 | Wentworth Timothy C (President) | Sale | 105,677 | 70.47 | 7,447,058 |
| 2014-05-27 | Wentworth Timothy C (President) | Option Ex | 127,189 | 47.05 | 5,984,242 |
Insider trading activities including stock purchases, stock sales, and option exercises of ESRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Express Scripts Holding Co. (symbol ESRX, CIK number 1532063) see the Securities and Exchange Commission (SEC) website.